Artykuły w czasopismach na temat „Reverse docking”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Reverse docking”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Soto Zuluaga, Juan Pablo, Marcus Thiell i Rosa Colomé Perales. "Reverse cross-docking". Omega 66 (styczeń 2017): 48–57. http://dx.doi.org/10.1016/j.omega.2016.01.010.
Pełny tekst źródłaListyani, Tiara Ajeng, i Rina Herowati. "Analisis Docking Molekuler Senyawa Derivat Phthalimide sebagai Inhibitor Non-Nukleosida HIV-1 Reverse Transcriptase". Jurnal Farmasi Indonesia 15, nr 2 (1.11.2018): 123–34. http://dx.doi.org/10.31001/jfi.v15i2.445.
Pełny tekst źródłaSeal, Abhik, Riju Aykkal i Mriganka Ghosh Ghosh. "Docking study of HIV-1 reverse transcriptase with phytochemicals". Bioinformation 5, nr 10 (15.02.2011): 430–39. http://dx.doi.org/10.6026/97320630005430.
Pełny tekst źródłaPark, Kichul, i Art E. Cho. "Using reverse docking to identify potential targets for ginsenosides". Journal of Ginseng Research 41, nr 4 (październik 2017): 534–39. http://dx.doi.org/10.1016/j.jgr.2016.10.005.
Pełny tekst źródłaDA SILVA, CARLOS H. T. P., IVONE CARVALHO i CARLTON A. TAFT. "MOLECULAR DYNAMICS, DOCKING, DENSITY FUNCTIONAL, AND ADMET STUDIES OF HIV-1 REVERSE TRANSCRIPTASE INHIBITORS". Journal of Theoretical and Computational Chemistry 05, nr 03 (wrzesień 2006): 579–86. http://dx.doi.org/10.1142/s0219633606002441.
Pełny tekst źródłaResti, Lady Ichwana, Herman Mawengkang i Elly Rosmaini. "Mathematical Model for Vehicle Routing and Scheduling with Forward and Reverse Logistics". Sinkron 8, nr 3 (1.07.2023): 1536–43. http://dx.doi.org/10.33395/sinkron.v8i3.12599.
Pełny tekst źródłaWang, Yan, Aidong Wang, Jianhua Wang, Xiaoran Wu, Yijie Sun i Yan Wu. "Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase". Molecules 27, nr 21 (29.10.2022): 7348. http://dx.doi.org/10.3390/molecules27217348.
Pełny tekst źródłaByler, Kendall, i William Setzer. "Protein Targets of Frankincense: A Reverse Docking Analysis of Terpenoids from Boswellia Oleo-Gum Resins". Medicines 5, nr 3 (31.08.2018): 96. http://dx.doi.org/10.3390/medicines5030096.
Pełny tekst źródłaRuswanto, Ruswanto, Richa Mardianingrum, Siswandono Siswandono i Dini Kesuma. "Reverse Docking, Molecular Docking, Absorption, Distribution, and Toxicity Prediction of Artemisinin as an Anti-diabetic Candidate". Molekul 15, nr 2 (27.07.2020): 88. http://dx.doi.org/10.20884/1.jm.2020.15.2.579.
Pełny tekst źródłaRiza, Hafrizal, Andhi Fahrurroji, Arif Wicaksono, Ahmad Kharis Nugroho i Sudibyo Martono. "DOCKING STUDY OF METHYL HESPERIDIN AS NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR". International Journal of Pharmacy and Pharmaceutical Sciences 10, nr 3 (1.03.2018): 85. http://dx.doi.org/10.22159/ijpps.2018v10i3.22724.
Pełny tekst źródła., T. B. Kakade. "Homology Modeling and Docking Studies on HIV Reverse Transcriptase Inhibitors". Journal of Current Pharma Research 3, nr 3 (15.05.2013): 965–82. http://dx.doi.org/10.33786/jcpr.2013.v03i03.010.
Pełny tekst źródłaSaleem, Mehmood, Mehar, Khan, Khan, Ashraf, Ali i in. "Bioassay Directed Isolation, Biological Evaluation and in Silico Studies of New Isolates from Pteris cretica L." Antioxidants 8, nr 7 (19.07.2019): 231. http://dx.doi.org/10.3390/antiox8070231.
Pełny tekst źródłaIksan, Muhamad, Frida M. Yusuf, Fitriani Fitriani B i Wa Ode Al Zarliani. "Antipyretic Drug Candidates Through Reverse Docking Techniques Used In Science Learning". Jurnal Penelitian Pendidikan IPA 9, nr 8 (25.08.2023): 6398–405. http://dx.doi.org/10.29303/jppipa.v9i8.4863.
Pełny tekst źródłaTong, Jianbo, Shan Lei, Pei Zhan, Shangshang Qin i Yang Wang. "QSAR and Docking Studies of DATA Analogues as HIV-1 Reverse Transcriptase Inhibitors". Letters in Drug Design & Discovery 16, nr 2 (29.11.2018): 153–59. http://dx.doi.org/10.2174/1570180815666180413152636.
Pełny tekst źródłaSavita, Mahendra Kumar, Neha Bora, Ruby Singh i Prachi Srivastava. "Screening of camphene as a potential inhibitor targeting SARS-CoV-2 various structural and functional mutants: Through reverse docking approach". Environmental Health Engineering and Management 10, nr 2 (27.05.2023): 123–29. http://dx.doi.org/10.34172/ehem.2023.14.
Pełny tekst źródłaDarme, Pierre, Manuel Dauchez, Arnaud Renard, Laurence Voutquenne-Nazabadioko, Dominique Aubert, Sandie Escotte-Binet, Jean-Hugues Renault, Isabelle Villena, Luiz-Angelo Steffenel i Stéphanie Baud. "AMIDE v2: High-Throughput Screening Based on AutoDock-GPU and Improved Workflow Leading to Better Performance and Reliability". International Journal of Molecular Sciences 22, nr 14 (13.07.2021): 7489. http://dx.doi.org/10.3390/ijms22147489.
Pełny tekst źródłaKotadiya, Manisha, i Ravi Ajudia. "In-silico Docking and ADME Studies of Natural Phytoconstituents from Different Medicinal Plants as Potential HIV Reverse Transcriptase Inhibitors". INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 15, nr 01 (25.03.2024): 115–18. http://dx.doi.org/10.25258/ijpqa.15.1.18.
Pełny tekst źródłaKharkar, Prashant S., Sona Warrier i Ram S. Gaud. "Reverse docking: a powerful tool for drug repositioning and drug rescue". Future Medicinal Chemistry 6, nr 3 (marzec 2014): 333–42. http://dx.doi.org/10.4155/fmc.13.207.
Pełny tekst źródłaKawsar, Sarkar Mohammad Abe, Mohammed Anowar Hosen, Tasneem Sultana Chowdhury, Kazi Masud Rana, Yuki Fujii i Yasuhiro Ozeki. "Thermochemical, PASS, Molecular Docking, Drug-Likeness and In Silico ADMET Prediction of Cytidine Derivatives against HIV-1 Reverse Transcriptase". Revista de Chimie 72, nr 3 (29.07.2021): 159–78. http://dx.doi.org/10.37358/rc.21.3.8446.
Pełny tekst źródłaEarlia, Nanda, Muslem, Rivansyah Suhendra, Mohamad Amin, C. R. S. Prakoeswa, Khairan i Rinaldi Idroes. "GC/MS Analysis of Fatty Acids on Pliek U Oil and Its Pharmacological Study by Molecular Docking to Filaggrin as a Drug Candidate in Atopic Dermatitis Treatment". Scientific World Journal 2019 (3.11.2019): 1–7. http://dx.doi.org/10.1155/2019/8605743.
Pełny tekst źródłaAldholmi, Mohammed, Rizwan Ahmad, Mohammad Habeeb Shaikh, Ayad Mohammed Salem, Maher Alqurashi i Mansour Alturki. "Anti-Infective Activity of Momordica charantia Extract with Molecular Docking of Its Triterpenoid Glycosides". Antibiotics 13, nr 6 (11.06.2024): 544. http://dx.doi.org/10.3390/antibiotics13060544.
Pełny tekst źródłaHarriman, D. Joseph, i Ghislain Deslongchamps. "Reverse-docking as a computational tool for the study of asymmetric organocatalysis". Journal of Computer-Aided Molecular Design 18, nr 5 (maj 2004): 303–8. http://dx.doi.org/10.1023/b:jcam.0000047813.47656.36.
Pełny tekst źródłaZhang, Haiping, Jianbo Pan, Xuli Wu, Ai-Ren Zuo, Yanjie Wei i Zhi-Liang Ji. "Large-Scale Target Identification of Herbal Medicine Using a Reverse Docking Approach". ACS Omega 4, nr 6 (4.06.2019): 9710–19. http://dx.doi.org/10.1021/acsomega.9b00020.
Pełny tekst źródłaHarriman, D. Joseph, i Ghislain Deslongchamps. "Reverse-docking study of the TADDOL-catalyzed asymmetric hetero-Diels–Alder reaction". Journal of Molecular Modeling 12, nr 6 (23.02.2006): 793–97. http://dx.doi.org/10.1007/s00894-006-0097-z.
Pełny tekst źródłaLee, Aeri, Kyoungyeul Lee i Dongsup Kim. "Using reverse docking for target identification and its applications for drug discovery". Expert Opinion on Drug Discovery 11, nr 7 (czerwiec 2016): 707–15. http://dx.doi.org/10.1080/17460441.2016.1190706.
Pełny tekst źródłaChandra, Priyanka, Swastika Ganguly i Soikata Karmakar. "Comparative Studies of Various NNRTIs in the Active Site of Different HIV-1RT Receptors". Chemistry Proceedings 3, nr 1 (14.11.2020): 33. http://dx.doi.org/10.3390/ecsoc-24-08313.
Pełny tekst źródłaK., Sony Jacob, i Swastika Ganguly. "A BATTLE AGAINST AIDS: NEW PYRAZOLE KEY TO AN OLDER LOCK-REVERSE TRANSCRIPTASE". International Journal of Pharmacy and Pharmaceutical Sciences 8, nr 11 (28.10.2016): 75. http://dx.doi.org/10.22159/ijpps.2016v8i11.12634.
Pełny tekst źródłaTshering, Kipchu, i Mir Misbahuddin. "In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer". Bangabandhu Sheikh Mujib Medical University Journal 9, nr 3 (21.09.2016): 164. http://dx.doi.org/10.3329/bsmmuj.v9i3.29650.
Pełny tekst źródłaWang, Junmei, Xinshan Kang, Irwin D. Kuntz i Peter A. Kollman. "Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM−PB/SA". Journal of Medicinal Chemistry 48, nr 7 (kwiecień 2005): 2432–44. http://dx.doi.org/10.1021/jm049606e.
Pełny tekst źródłaNugraha, Rivo YB, Icha FD Faratisha, Kana Mardhiyyah, Dio G. Ariel, Fitria F. Putri, Nafisatuzzamrudah, Sri Winarsih, Teguh W. Sardjono i Loeki E. Fitri. "Antimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach". BioMed Research International 2020 (9.01.2020): 1–15. http://dx.doi.org/10.1155/2020/6135696.
Pełny tekst źródłaTien, Nguyen Truong, i Bui Tho Thanh. "Predicting binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase using molecular docking". Science and Technology Development Journal - Natural Sciences 2, nr 1 (6.01.2019): 53–58. http://dx.doi.org/10.32508/stdjns.v2i1.674.
Pełny tekst źródłaKhan, Mahmood-ul-Hassan, Shahid Hameed, Muhammad Farman, Najim A. Al-Masoudi i Helen Stoeckli-Evans. "Synthesis, anti-HIV activity and molecular modeling study of 3-aryl-6-adamantylmethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives". Zeitschrift für Naturforschung B 70, nr 8 (1.08.2015): 609–16. http://dx.doi.org/10.1515/znb-2015-0032.
Pełny tekst źródłaKonyar, Dilan, i Muhammed Tılahun Muhammed. "MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATIONS INHIBITION AGAINST OF HUMAN TELOMERASE BY NUCLEOSIDE AND NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs/NNRTIs)". Ankara Universitesi Eczacilik Fakultesi Dergisi 48, nr 2 (17.04.2024): 18. http://dx.doi.org/10.33483/jfpau.1444259.
Pełny tekst źródłaTarasova, Olga, Vladimir Poroikov i Alexander Veselovsky. "Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review". Molecules 23, nr 5 (21.05.2018): 1233. http://dx.doi.org/10.3390/molecules23051233.
Pełny tekst źródłaFan, Shengjun, Qiang Geng, Zhenyu Pan, Xin Li, Lu Tie, Yan Pan i Xuejun Li. "Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach". BMC Systems Biology 6, nr 1 (2012): 152. http://dx.doi.org/10.1186/1752-0509-6-152.
Pełny tekst źródłaBillones, Junie. "Reverse docking study unravels the potential Mycobacterium tuberculosis enzyme targets of Agelasine F". Oriental Journal of Chemistry 32, nr 2 (25.04.2016): 851–58. http://dx.doi.org/10.13005/ojc/320210.
Pełny tekst źródłaJoseph Harriman, D., Glen F. Deleavey, Andreas Lambropoulos i Ghislain Deslongchamps. "Reverse-docking study of the organocatalyzed asymmetric Strecker hydrocyanation of aldimines and ketimines". Tetrahedron 63, nr 52 (grudzień 2007): 13032–38. http://dx.doi.org/10.1016/j.tet.2007.10.009.
Pełny tekst źródłaRagno, Rino, Simona Frasca, Fabrizio Manetti, Antonella Brizzi i Silvio Massa. "HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies". Journal of Medicinal Chemistry 48, nr 1 (styczeń 2005): 200–212. http://dx.doi.org/10.1021/jm0493921.
Pełny tekst źródłaKheirkhah, Amirsaman, i Saeid Rezaei. "Using cross-docking operations in a reverse logistics network design: a new approach". Production Engineering 10, nr 2 (28.11.2015): 175–84. http://dx.doi.org/10.1007/s11740-015-0646-3.
Pełny tekst źródłaPitta, Eleni, Evangelia Tsolaki, Athina Geronikaki, Jovana Petrović, Jasmina Glamočlija, Marina Soković, Emmanuele Crespan, Giovanni Maga, Shome S. Bhunia i Anil K. Saxena. "4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies". MedChemComm 6, nr 2 (2015): 319–26. http://dx.doi.org/10.1039/c4md00399c.
Pełny tekst źródłaAlharbi, Ahmed. "Molecular docking based design of Inhibitors for viral Non-Nucleosidase as potential anti-retroviral agents". Bioinformation 16, nr 10 (31.10.2020): 736–41. http://dx.doi.org/10.6026/97320630016736.
Pełny tekst źródłaGong, Chang, Zihao Liu, Qun Lin, Yu Shi, Qing Luo, Yinghuan Cen, Juanmei Li, Xiaolin Fang i Wenguo Jiang. "Anti-PITPNM3 small molecular compounds reverse breast cancer metastasis by targeting PITPNM3." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): e15005-e15005. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15005.
Pełny tekst źródłaChandra, Priyanka, Swastika Swastika i Manik Ghosh. "In Silico Studies of Piperazinyl-4-Nitroimidazole Derivatives in the Non-Nucleoside Inhibitory Binding Pocket of Human Immunodeficiency Virus-1-Reverse Transcriptase Enzyme". INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 33, nr 03 (30.09.2023): 293. http://dx.doi.org/10.59467/ijhc.2023.33.293.
Pełny tekst źródłaKrishnamoorthy, Praveen K. P., Sekar Subasree, Udhayachandran Arthi, Mohammad Mobashir, Chirag Gowda i Prasanna D. Revanasiddappa. "T-cell Epitope-based Vaccine Design for Nipah Virus by Reverse Vaccinology Approach". Combinatorial Chemistry & High Throughput Screening 23, nr 8 (2.11.2020): 788–96. http://dx.doi.org/10.2174/1386207323666200427114343.
Pełny tekst źródłaRasyadan Taufiq Probojati, Ahmad Affan Ali Murtadlo, Md. Emdad Ullah, Sin War Naw i Dora Dayu Rahma Turista. "Molecular Docking Study of HIV-1 Antiretroviral Candidate via Reverse Transcriptase Inhibitor from Zingiber officinale var. Roscoe". SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics 1, nr 01 (9.06.2022): 26–31. http://dx.doi.org/10.24036/sainstek/vol1-iss01/6.
Pełny tekst źródłaWang, Yueping, Jie Chang, Jiangyuan Wang, Peng Zhong, Yufang Zhang, Christopher Cong Lai i Yanping He. "3D-QSAR Studies of S-DABO Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors". Letters in Drug Design & Discovery 16, nr 8 (8.08.2019): 868–81. http://dx.doi.org/10.2174/1570180815666180810112321.
Pełny tekst źródłaMukherjee, Taniya, Isha Sangal, Biswajit Sarkar, Qais Almaamari i Tamer M. Alkadash. "How Effective Is Reverse Cross-Docking and Carbon Policies in Controlling Carbon Emission from the Fashion Industry?" Mathematics 11, nr 13 (27.06.2023): 2880. http://dx.doi.org/10.3390/math11132880.
Pełny tekst źródłaRotich, Winnie, Nicholas J. Sadgrove, Eduard Mas-Claret, Guillermo F. Padilla-González, Anastasia Guantai i Moses K. Langat. "HIV-1 Reverse Transcriptase Inhibition by Major Compounds in a Kenyan Multi-Herbal Composition (CareVid™): In Vitro and In Silico Contrast". Pharmaceuticals 14, nr 10 (30.09.2021): 1009. http://dx.doi.org/10.3390/ph14101009.
Pełny tekst źródłaIslam, Sk Injamamul, Saloa Sanjida, Sheikh Sunzid Ahmed, Mazen Almehmadi, Mamdouh Allahyani, Abdulelah Aljuaid, Ahad Amer Alsaiari i Mustafa Halawi. "Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease". Vaccines 10, nr 10 (7.10.2022): 1669. http://dx.doi.org/10.3390/vaccines10101669.
Pełny tekst źródłaSree Latha, Ramaswamy, Ramadoss Vijayaraj, Ettayapuram Ramaprasad Azhagiya Singam, Krishnaswamy Chitra i Venkatesan Subramanian. "3D-QSAR and Docking Studies on the HEPT Derivatives of HIV-1 Reverse Transcriptase". Chemical Biology & Drug Design 78, nr 3 (29.07.2011): 418–26. http://dx.doi.org/10.1111/j.1747-0285.2011.01162.x.
Pełny tekst źródła